MAIA Biotechnology, Inc is a Chicago-based biotech company specializing in telomere targeting immunotherapies for cancer. With a strong management team, board of directors, and scientific advisors, MAIA is dedicated to developing innovative treatments to combat cancer through their THIO Program and second-generation programs.
Through their research and development efforts, MAIA aims to revolutionize cancer treatment and improve patient outcomes. With a focus on telomere targeting immunotherapies, they are at the forefront of cutting-edge advancements in the field, positioning themselves as a key player in the fight against cancer.
Generated from the website